Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Modifying Glucose Metabolism Reverses Memory Defects of Alzheimer's Disease Model at Late Stages.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Same author

Application of electromyographic biofeedback therapy in physical dysfunction rehabilitation and post-stroke anxiety reduction in stroke survivors.

World journal of psychiatry·2025

Same author

Central Med23 deficiency leads to malformation of dentate gyrus and ADHD-like behaviors in mice.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2025

Same author

Depicting Primate-Like Granular Dorsolateral Prefrontal Cortex in the Chinese Tree Shrew.

eNeuro·2024

Same author

Hippocampal dipeptidyl peptidase 9 bidirectionally regulates memory associated with synaptic plasticity.

Journal of advanced research·2024

Same author

Multisystem ALK-positive histiocytosis: a multi-case study and literature review.

Orphanet journal of rare diseases·2023

Search research articles

Related Experiment Video

Updated: Apr 6, 2026

Author Spotlight: Enhancing Multicolor Fluorescence Localization in Lung Carcinoma Sample

Author Spotlight: Enhancing Multicolor Fluorescence Localization in Lung Carcinoma Sample

Published on: November 21, 2023

Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.

Xue-Ying Su¹, Wei-Ya Wang¹, Jin-Nan Li¹

¹Department of Pathology, West China Hospital of Sichuan University Chengdu 610041, China.

International Journal of Clinical and Experimental Pathology

|July 21, 2015

Summary

Diagnosing thymic tumors can be challenging. This study identifies new markers like GLUT-1 and MUC-1 to accurately differentiate Type B3 thymomas from thymic squamous cell carcinomas, improving diagnostic accuracy.

Keywords:

Type B3 thymoma differentiation immunohistochemistry thymic squamous cell carcinoma

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

Related Experiment Videos

Last Updated: Apr 6, 2026

Author Spotlight: Enhancing Multicolor Fluorescence Localization in Lung Carcinoma Sample

Author Spotlight: Enhancing Multicolor Fluorescence Localization in Lung Carcinoma Sample

Published on: November 21, 2023

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

Area of Science:

Pathology
Oncology
Immunohistochemistry

Background:

Type B3 thymomas and thymic squamous cell carcinomas share histological similarities, complicating differential diagnosis, especially with small biopsy samples.
Current diagnostic markers like CD5 and CD117 have limitations in distinguishing these entities.

Purpose of the Study:

To identify novel immunohistochemical markers for accurate differential diagnosis between Type B3 thymoma and thymic squamous cell carcinoma.
To evaluate the sensitivity and specificity of various markers in distinguishing these two thymic neoplasms.

Main Methods:

Evaluated GLUT-1, MUC-1, CD117, CD5, CEA, P63, CK19, CK5/6, CD1a, and TdT expression in 16 Type B3 thymomas and 20 thymic squamous cell carcinomas.
Quantified marker expression using staining scores based on the percentage of positive cells.

Main Results:

GLUT-1 and MUC-1 showed 100% sensitivity for thymic squamous cell carcinomas; CD5, CD117, and CEA demonstrated 100% specificity.
CK19, TdT, and CD1a exhibited high sensitivity (100%, 93.8%, 87.5%) for Type B3 thymomas, with CD1a showing 100% specificity.
Significant differences in marker reactivity were observed between the two tumor types.

Conclusions:

A combination of markers, particularly GLUT-1 or MUC-1 with highly specific markers (CD5, CD117, CEA, CD1a, TdT), can effectively differentiate Type B3 thymomas from thymic squamous cell carcinomas.
These findings aid in improving the accuracy of diagnosing challenging thymic neoplasms, especially from limited biopsy material.